Related Experiment Video
Updated: Jan 24, 2026

Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion
Published on: March 18, 2014
Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic
Robert M Hughes1,2,3, Brian W Simons1, Hamda Khan1,2,3
1The James Buchanan Brady Urological Institute, Department of Urology, Johns Hopkins School of Medicine, Baltimore, Maryland.
Abstract:
Tumor progression to metastasis is not cancer cell autonomous, but rather involves the interplay of multiple cell types within the tumor microenvironment. Here we identify asporin (ASPN) as a novel, secreted mesenchymal stromal cell (MSC) factor in the tumor microenvironment that regulates metastatic development. MSCs expressed high levels of ASPN, which decreased following lineage differentiation. ASPN loss impaired MSC self-renewal and promoted terminal cell differentiation. Mechanistically, secreted ASPN bound to BMP-4 and restricted BMP-4-induced MSC differentiation prior to lineage commitment. ASPN expression was distinctly conserved between MSC and cancer-associated fibroblasts (CAF). ASPN expression in the tumor microenvironment broadly impacted multiple cell types. Prostate tumor allografts in ASPN-null mice had a reduced number of tumor-associated MSCs, fewer cancer stem cells, decreased tumor vasculature, and an increased percentage of infiltrating CD8+ T cells. ASPN-null mice also demonstrated a significant reduction in lung metastases compared with wild-type mice. These data establish a role for ASPN as a critical MSC factor that extensively affects the tumor microenvironment and induces metastatic progression. SIGNIFICANCE: These findings show that asporin regulates key properties of mesenchymal stromal cells, including self-renewal and multipotency, and asporin expression by reactive stromal cells alters the tumor microenvironment and promotes metastatic progression.
Insights
Asporin (ASPN), a factor from mesenchymal stromal cells (MSCs), drives tumor metastasis by altering the tumor microenvironment. Blocking ASPN reduces metastasis and impacts tumor-associated cells.
Area of Science:
- Oncology
- Cell Biology
- Tumor Microenvironment Research
Background:
- Tumor metastasis involves complex interactions within the tumor microenvironment, not just cancer cells.
- Mesenchymal stromal cells (MSCs) are key components of this microenvironment, influencing tumor progression.
Purpose of the Study:
- To identify novel factors secreted by MSCs that regulate metastatic development.
- To elucidate the role of asporin (ASPN) in the tumor microenvironment and its impact on metastasis.
Main Methods:
- Investigated ASPN expression in MSCs and its correlation with differentiation.
- Utilized ASPN-null mice to assess the in vivo impact of ASPN on prostate tumor growth and metastasis.
- Analyzed tumor microenvironment composition, including MSCs, cancer stem cells, vasculature, and immune cells.
Main Results:
- ASPN is highly expressed in MSCs and regulates their self-renewal and differentiation.
- Secreted ASPN binds BMP-4, inhibiting MSC differentiation.
- ASPN expression is conserved in cancer-associated fibroblasts (CAFs).
- ASPN-null mice exhibited reduced tumor-associated MSCs, fewer cancer stem cells, decreased vasculature, and increased CD8+ T cells.
- ASPN deficiency significantly reduced lung metastases in prostate tumor models.
Conclusions:
- Asporin (ASPN) is a critical secreted factor from mesenchymal stromal cells (MSCs) that promotes tumor metastatic progression.
- ASPN extensively modulates the tumor microenvironment, affecting multiple cell types and promoting metastasis.
- Targeting ASPN may represent a novel therapeutic strategy to inhibit cancer metastasis.
More Related Videos
Related Concept Videos
The Tumor Microenvironment
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Mesenchymal Stem Cells
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...
Alterations in Respiration II
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...
Restriction Enzymes
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...

